ICL vascular implant spinout Veryan Medical has been bought by medical device firm Otsuka after raising $56m from investors including IP Group.

Veryan Medical, a UK-based vascular implant spinout from Imperial College London, has been acquired by medical device manufacturer Otsuka Medical Devices for an undisclosed exit, allowing commercialisation firm IP Group to exit.
Founded in 2003, Veryan has devised a vascular flow stent with a 3D helical shape designed to reflect natural curvatures in the body’s arterial system.
The stent, dubbed Swirling Flow, is intended to treat peripheral vascular disease by improving blood circulation to the target area while…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?